Clinical Trials in Massachusetts

Showing 11921-11940 of 15,316 trials

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

NCT00765921

The purpose of the study is to investigate the safety and tolerability of the anti-VEGF (vascular endothelial cell growth factor) treatment, ranibizumab, in combination with proton beam irradiation for the treatment of choroidal melanoma by determining the incidence and severity of ocular adverse events. Systemic adverse events will also be evaluated. A secondary objective is to assess the efficacy of ranibizumab in reducing ocular complications that can occur after irradiation.

Choroidal Melanoma

Massachusetts Eye and Ear Infirmary40 participantsStarted Jun 2008

Boston, Massachusetts, United States

COMPLETEDPhase 226 miles

An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks

NCT00695305

A study in patients with atherosclerosis to assess safety, effect and PK of rilapladib vs. placebo over 12 weeks of dosing.

Atherosclerosis

GlaxoSmithKline83 participantsStarted Nov 2008

Boston, Massachusetts, United States • Brockton, Massachusetts, United States • Haverhill, Massachusetts, United States +7 more locations

COMPLETEDPhase 426 miles

Supplementation in Adolescent Girls With Endometriosis

NCT02387931

The purpose of this study is to determine whether dietary supplementation with Vitamin D or Fish Oil can help to reduce physical and emotional symptoms in adolescent girls with endometriosis.

Endometriosis

Boston Children's Hospital69 participantsStarted Sep 2014

Boston, Massachusetts, United States

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks

Supplementation in Adolescent Girls With Endometriosis

Find Trials by Condition in Massachusetts

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

Switching From Oral Dopamine Agonists to Rotigotine

Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer

A-protein Levels in Adult and Pediatric Brain Tumor Patients

Assessing the CenteringPregnancy Planning to Parent Innovation

CliniMACS® CD34+ Reagent System for Expanded Access Use

Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)